Low molecular weight heparin for hickman catheter-induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation
Open Access
- 1 October 1992
- Vol. 70 (7) , 1895-1898
- https://doi.org/10.1002/1097-0142(19921001)70:7<1895::aid-cncr2820700715>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Low molecular weight heparinBlood, 1992
- HeparinNew England Journal of Medicine, 1991
- Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantationCancer, 1990
- Complications of central venous cannulation.BMJ, 1988
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Heparin-induced ThrombocytopeniaChest, 1985
- Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216)Seminars in Thrombosis and Hemostasis, 1985
- Heparin-Associated ThrombocytopeniaAnnals of Internal Medicine, 1984
- Occlusion and infection in broviac catheters during intensive cancer therapyCancer, 1983
- The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombinBiochemical Journal, 1981